Regeneron Pharmaceuticals Inc Congressional Trading
According to U.S. congressional financial disclosures filed under the STOCK Act, members of Congress have reported 236 trades in Regeneron Pharmaceuticals Inc (NASDAQ: REGN) since 2013, across 28 members, worth an estimated $4.8M in disclosed volume (the midpoint of the dollar ranges members report, not exact amounts). 131 buys against 105 sells, a modestly buy-led skew, with Democratic members responsible for 53% of the trades and Republican members 47%. The most recent disclosure shown was filed August 2026, and Rohit Khanna has filed the most REGN transactions among those shown, with 11. Other recent filers include Gilbert Cisneros, Alan Armstrong, and Julia Letlow. One notable disclosed move was a purchase by Rohit Khanna on August 26, 2025, up 42.4% since. These figures are drawn from public House and Senate periodic transaction reports and reflect what members were required to disclose, not the current market value of any position. Regeneron Pharmaceuticals Inc's current Quantellect Tide Score is 48 out of 100 (High Tide), Bottom 48% of universe (3876); the Tide Score is generated algorithmically from public filings and market data and is not investment advice. For the full record, including the month-by-month buy and sell timeline, the party breakdown, top buyers and sellers, and every individual filing, see the Regeneron Pharmaceuticals Inc (REGN) stock overview and the complete trade table below.
Data updated
Price & congressional trade timeline
Party breakdown
Regeneron Pharmaceuticals congressional trading activity
| Politician | Published | Traded | Filed After | Type | Size | Return | Owner | |
|---|---|---|---|---|---|---|---|---|
 Rohit Khanna House | Aug 7, 2026 | Jul 7, 2026 | 31 days | BUY |  $1,001 - $15,000 | +23.27% | Child | |
Rohit Khanna House | Jul 6, 2026 | Jun 16, 2026 | 20 days | BUY | $1,001 - $15,000 | +35.60% | Spouse | |
Rohit Khanna House | Jul 6, 2026 | Jun 2, 2026 | 34 days | SELL | $1,001 - $15,000 | +38.25% | Child | |
Rohit Khanna House | Jun 9, 2026 | May 15, 2026 | 25 days | SELL | $1,001 - $15,000 | +19.56% | Spouse | |
 Gilbert Cisneros House | Jun 8, 2026 | May 15, 2026 | 24 days | SELL | $1,001 - $15,000 | +19.56% | Self | |
Rohit Khanna House | Jun 9, 2026 | May 1, 2026 | 39 days | SELL | $1,001 - $15,000 | +19.02% | Child | |
Rohit Khanna House | May 11, 2026 | Apr 13, 2026 | 28 days | BUY | $1,001 - $15,000 | +11.84% | Spouse | |
 Alan Armstrong Senate | Jul 21, 2026 | Mar 27, 2026 | 116 days | BUY | $1,001 - $15,000 | +13.16% | Self | |
 Julia Letlow House | Mar 12, 2026 | Feb 12, 2026 | 28 days | BUY | $1,001 - $15,000 | +6.66% | Self | |
Rohit Khanna House | Feb 6, 2026 | Jan 29, 2026 | 8 days | SELL | $1,001 - $15,000 | +11.52% | Spouse |
Regeneron Pharmaceuticals (REGN) congressional trading FAQ
Can members of Congress legally trade Regeneron Pharmaceuticals (REGN) stock?
Yes. Members of Congress are permitted to trade individual stocks, including Regeneron Pharmaceuticals (REGN), but the STOCK Act of 2012 requires them to publicly disclose each transaction within 45 days. Quantellect tracks those disclosures; it does not imply any trade was improper.
Are congressional Regeneron Pharmaceuticals (REGN) trades public?
Yes. Every congressional trade in Regeneron Pharmaceuticals (REGN) on this page comes from mandatory public STOCK Act disclosure filings, which are filed with a delay and may be revised.
How many times has Congress traded Regeneron Pharmaceuticals (REGN)?
Members of Congress have disclosed 236 trades in Regeneron Pharmaceuticals (REGN) worth $4.8M across 28 members, according to public STOCK Act filings.
Which members of Congress have traded Regeneron Pharmaceuticals (REGN)?
Recent and active filers of Regeneron Pharmaceuticals (REGN) disclosures include Rohit Khanna, Gilbert Cisneros, Alan Armstrong. The full member-by-member trade list is on this page.
Do Democrats or Republicans trade Regeneron Pharmaceuticals (REGN) more?
Across disclosed Regeneron Pharmaceuticals (REGN) trades, 53% were by Democrats and 47% by Republicans, led by Democrats (53%).
What is the most recent congressional Regeneron Pharmaceuticals (REGN) trade?
The most recent disclosed Regeneron Pharmaceuticals (REGN) trade was a purchase by Rohit Khanna, filed Aug 6, 2026.
What is Regeneron Pharmaceuticals (REGN)'s Tide Score?
Regeneron Pharmaceuticals (REGN) has a Quantellect Tide Score of 48 (High Tide). The Tide Score is a 0-100 read blending price forecast, smart-money flow, technicals, and social sentiment; higher is more bullish.
Browse all stocks Congress tradesCongressional trading overviewRegeneron Pharmaceuticals (REGN) stock overview
Not investment advice. Congressional trading data is sourced from public STOCK Act disclosures, which are filed with a delay and may contain errors or be revised. The Tide Score and other figures are generated algorithmically from public filings and market data and describe historical activity, not a recommendation. Always do your own research and consult a licensed financial advisor before making investment decisions.